Giant cell arteritis Commentary on recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)
Publié : jeu. juin 14, 2018 11:22 am
Giant cell arteritis: Commentary on recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)
The recently created French Study Group for Large Vessel Vasculitis (GEFA, “ Groupe d’Étude Franc¸ ais des Artérites des gros vaisseaux”) is a multidisciplinary panel comprised of members committed to the care and study of patients with giant cell arteritis (GCA).
While our understanding of the vasculitides has grown, much remains unknown. Treatment is not curative and is associated with significant morbidity .
In hoping to inform and guide practitioners, GEFA members have attempted to achieve at least 80% consensus on recommendations for nomenclature, diagnosis and treatment. For each of these topics there exists varying degrees of controversy, making a rigorous examination of available data and provision of sound advice especially welcome.
The iterative, consensus-seeking approach taken by GEFA members has been successful and is an important contribution for guiding medical practice. In a field thatthankfully continues to evolve, GEFA authors have been cautious to indicate that their judgments and recommendations are provisional and should be updated over time.
In that vein,this important paper also provides the reader with a compass to conceive of future work that will enrich the state of the art of large vessel vasculitis (LVV).
Lien masqué,veuillez vous inscrire et commenter pour voir le lien de téléchargement,merci.
link :
The recently created French Study Group for Large Vessel Vasculitis (GEFA, “ Groupe d’Étude Franc¸ ais des Artérites des gros vaisseaux”) is a multidisciplinary panel comprised of members committed to the care and study of patients with giant cell arteritis (GCA).
While our understanding of the vasculitides has grown, much remains unknown. Treatment is not curative and is associated with significant morbidity .
In hoping to inform and guide practitioners, GEFA members have attempted to achieve at least 80% consensus on recommendations for nomenclature, diagnosis and treatment. For each of these topics there exists varying degrees of controversy, making a rigorous examination of available data and provision of sound advice especially welcome.
The iterative, consensus-seeking approach taken by GEFA members has been successful and is an important contribution for guiding medical practice. In a field thatthankfully continues to evolve, GEFA authors have been cautious to indicate that their judgments and recommendations are provisional and should be updated over time.
In that vein,this important paper also provides the reader with a compass to conceive of future work that will enrich the state of the art of large vessel vasculitis (LVV).
Lien masqué,veuillez vous inscrire et commenter pour voir le lien de téléchargement,merci.
link :